Hyaluronic acid reduction-sensitive polymeric micelles achieving co-delivery of tumor-targeting paclitaxel/apatinib effectively reverse cancer multidrug resistance

• Príomhchruthaitheoirí: Xiaoqing Zhang (Údar), Xiaomei Ren (Údar), Jiayin Tang (Údar), Jiangtao Wang (Údar), Xiang Zhang (Údar), Peng He (Údar), Chang Yao (Údar), Weihe Bian (Údar), Lizhu Sun (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Multidrug resistance (MDR) of cancer cells is a significant challenge in chemotherapy, highlighting the urgent medical need for simple and reproducible strategies to reverse this process. Here, we report the development of an active tumor-targeting and redox-responsive nanoplatform (PA-ss-NP) using...